Towards Personalized Treatment and Molecular Research on Gastrointestinal Tumors

Int J Mol Sci. 2023 Sep 19;24(18):14283. doi: 10.3390/ijms241814283.

¹ Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Via P. Maroncelli 40, 47014 Meldola, Italy.
² Unit of Biostatistics and Clinical Trials, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Via P. Maroncelli 40, 47014 Meldola, Italy.
³ Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Via P. Maroncelli 40, 47014 Meldola, Italy.

Abstract

Gastrointestinal cancers (GC) account for 26% of all cancer incidences and 35% of all cancer-related deaths [...].